FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056353948> ?p ?o ?g. }

• W2056353948 endingPage "225" @default.
• W2056353948 startingPage "216" @default.
• W2056353948 abstract "Background and purpose: The metabolic syndrome, characterized by obesity, insulin resistance and dyslipidemia, is a major cause of cardiovascular disease. The origins of the syndrome have been hypothesized to lie in continuous availability of energy dense foods in modern societies. In contrast, human physiology has evolved in an environment of sporadic food supply and frequent food deprivation. Intermittent food restriction in rats has previously been shown to lead to reduction of cardiovascular risk and a greater life span. The non-metabolizable glucose analogue, 2-deoxy-D-glucose (2-DG) is taken up by cells and induces pharmacological inhibition of metabolism of glucose. We hypothesized that intermittent inhibition of glucose metabolism, a metabolic deprivation, may mimic intermittent food deprivation and ameliorate metabolic and pathophysiological aspects of the metabolic syndrome. Experimental approach: Insulin resistant, atherosclerosis-prone JCR:LA-cp rats were treated with 2-DG (0.3% w/w in chow) on an intermittent schedule (2 days treated, one day non-treated, two days treated and two days non-treated) or continuously at a dose to give an equivalent averaged intake. Key results: Intermittent 2-DG-treatment improved insulin sensitivity, which correlated with increased adiponectin concentrations. Further, intermittent treatment (but not continuous treatment) reduced plasma levels of leptin and the inflammatory cytokine IL-1β. Both 2-DG treatments reduced micro-vascular glomerular sclerosis, but only the intermittent schedule improved macro-vascular dysfunction. Conclusions and implications: Our findings are consistent with reduction in severity of the metabolic syndrome and protection against end stage micro- and macro-vascular disease through intermittent metabolic deprivation at a cellular level by inhibition of glucose oxidation with 2-DG. British Journal of Pharmacology (2007) 151, 216–225. doi:10.1038/sj.bjp.0707226" @default.
• W2056353948 created "2016-06-24" @default.
• W2056353948 creator A5040453423 @default.
• W2056353948 creator A5091643916 @default.
• W2056353948 date "2007-05-01" @default.
• W2056353948 modified "2023-09-26" @default.
• W2056353948 title "Increased insulin sensitivity and reduced micro and macro vascular disease induced by 2-deoxy-D-glucose during metabolic syndrome in obese JCR: LA-cprats" @default.
• W2056353948 cites W1500703952 @default.
• W2056353948 cites W1887653246 @default.
• W2056353948 cites W1921587687 @default.
• W2056353948 cites W1936333617 @default.
• W2056353948 cites W1952772062 @default.
• W2056353948 cites W1967785665 @default.
• W2056353948 cites W1972545707 @default.
• W2056353948 cites W1975487133 @default.
• W2056353948 cites W1977843798 @default.
• W2056353948 cites W1978133648 @default.
• W2056353948 cites W1978146038 @default.
• W2056353948 cites W2000056219 @default.
• W2056353948 cites W2000514316 @default.
• W2056353948 cites W2008804979 @default.
• W2056353948 cites W2020079510 @default.
• W2056353948 cites W2021284225 @default.
• W2056353948 cites W2023590870 @default.
• W2056353948 cites W2026808318 @default.
• W2056353948 cites W2027722653 @default.
• W2056353948 cites W2029480423 @default.
• W2056353948 cites W2035220960 @default.
• W2056353948 cites W2037631372 @default.
• W2056353948 cites W2038794302 @default.
• W2056353948 cites W2043458888 @default.
• W2056353948 cites W2046113619 @default.
• W2056353948 cites W2046211221 @default.
• W2056353948 cites W2049366781 @default.
• W2056353948 cites W2051889648 @default.
• W2056353948 cites W2059794176 @default.
• W2056353948 cites W2063381978 @default.
• W2056353948 cites W2076864486 @default.
• W2056353948 cites W2077018876 @default.
• W2056353948 cites W2079370492 @default.
• W2056353948 cites W2085118709 @default.
• W2056353948 cites W2087050793 @default.
• W2056353948 cites W2088233968 @default.
• W2056353948 cites W2089997943 @default.
• W2056353948 cites W2092586216 @default.
• W2056353948 cites W2096299680 @default.
• W2056353948 cites W2104761649 @default.
• W2056353948 cites W2125216566 @default.
• W2056353948 cites W2138195961 @default.
• W2056353948 cites W2138956360 @default.
• W2056353948 cites W2144838695 @default.
• W2056353948 cites W2146484653 @default.
• W2056353948 cites W2146589346 @default.
• W2056353948 cites W2146951461 @default.
• W2056353948 cites W2151290514 @default.
• W2056353948 cites W2156573004 @default.
• W2056353948 cites W2163599269 @default.
• W2056353948 cites W2164465462 @default.
• W2056353948 cites W2165355897 @default.
• W2056353948 cites W2165895027 @default.
• W2056353948 cites W2168541164 @default.
• W2056353948 cites W2169666341 @default.
• W2056353948 cites W2322346891 @default.
• W2056353948 cites W2330198372 @default.
• W2056353948 cites W2337133379 @default.
• W2056353948 cites W2340324006 @default.
• W2056353948 cites W2345404920 @default.
• W2056353948 cites W2416497810 @default.
• W2056353948 cites W2418780906 @default.
• W2056353948 cites W2418931032 @default.
• W2056353948 cites W4230837113 @default.
• W2056353948 doi "https://doi.org/10.1038/sj.bjp.0707226" @default.
• W2056353948 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2013948" @default.
• W2056353948 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17375078" @default.
• W2056353948 hasPublicationYear "2007" @default.
• W2056353948 type Work @default.
• W2056353948 sameAs 2056353948 @default.
• W2056353948 citedByCount "8" @default.
• W2056353948 countsByYear W20563539482016 @default.
• W2056353948 crossrefType "journal-article" @default.
• W2056353948 hasAuthorship W2056353948A5040453423 @default.
• W2056353948 hasAuthorship W2056353948A5091643916 @default.
• W2056353948 hasBestOaLocation W20563539481 @default.
• W2056353948 hasConcept C126322002 @default.
• W2056353948 hasConcept C134018914 @default.
• W2056353948 hasConcept C17093226 @default.
• W2056353948 hasConcept C2776782570 @default.
• W2056353948 hasConcept C2777391703 @default.
• W2056353948 hasConcept C2778096610 @default.
• W2056353948 hasConcept C2779306644 @default.
• W2056353948 hasConcept C2780578515 @default.
• W2056353948 hasConcept C2780613262 @default.
• W2056353948 hasConcept C511355011 @default.
• W2056353948 hasConcept C555293320 @default.
• W2056353948 hasConcept C71924100 @default.
• W2056353948 hasConceptScore W2056353948C126322002 @default.
• W2056353948 hasConceptScore W2056353948C134018914 @default.
• W2056353948 hasConceptScore W2056353948C17093226 @default.

• next